Human Longevity Inc., China (also known as Apollo8 Health) owns the exclusive China rights of Human Longevity Inc. (referred to as HLI). HLI is a genomics-based, data-driven medical technology company founded in 2013 by Dr. J. Craig Venter, the father of the human genome. In the field of preventive and precision medicine, the scientific research achievements of HLI are at the forefront of the world. HLI is devoted to using big data to accurately manage human health and predict future disease risks, with the aim of prolonging human lifespan and improving the quality of life.